Get in Touch
Ready to accelerate your product lifecycle? Schedule a consultation or reach out to learn more about how we can help.
Frequently Asked Questions
We work across life sciences — biotech, pharma, medical devices, diagnostics, cell & gene therapy, digital health, and rare disease companies.
We offer project-based consulting, interim leadership, board advisory, and strategic partnerships. Engagements range from short-term projects to long-term retained advisory relationships.
Timelines vary based on scope. Some strategic analyses take 6-8 weeks, while longer engagements (M&A due diligence, launch readiness) may span 3-6 months or more.
Yes. We work with companies at all stages — from preclinical through commercial. We understand the unique constraints and opportunities of emerging biotech companies.
Yes. We help companies prepare investor decks, data rooms, materials for capital raises, and strategic communications for fundraising events and roadshows.
We maintain strict confidentiality agreements with all clients. All work is conducted under NDA, and we have decades of experience working with sensitive proprietary information.